Maria C. Hernandez-Calles
Palma, PM 07120, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: April 15, 2026
12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II).
Journal: Revista de neurologia
Published: May 22, 2020
12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)
Journal: Revista de neurologia
Published: May 12, 2020
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).
Journal: Revista de neurologia
Published: May 28, 2019
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)
Journal: Revista de neurologia
Published: May 10, 2019
Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (II)
Journal: Revista de neurologia
Published: July 05, 2018
Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (I)
Journal: Revista de neurologia
Published: June 21, 2018
Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I).
Journal: Revista de neurologia
Published: June 27, 2017
Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting.
Journal: Revista de neurologia
Published: June 09, 2016
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Journal: Revista de neurologia
Published: September 10, 2015
Last Updated: 09/26/2026